Health
Connect America Named to AVIA Marketplace’s Top Remote Patient Monitoring Companies
BALA-CYNWYD, Pa., June 20, 2023 (Newswire.com) - Connect America, a nationally recognized innovator in virtual connective care solutions in the home that enable older adults and those living with chronic conditions to live safe and well, announced today that it was recognized as a Top Company in Remote Patient Monitoring upon conclusion of extensive research and company outreach by AVIA Marketplace, the leading digital health marketplace.
The Connect America Homeâ„¢ platform, which includes their RPM solution powered by 100Plus, enables healthcare providers to deliver better care for patients in the comfort of their homes while remotely managing their chronic conditions. In addition to remote monitoring services, the company's complete end-to-end platform includes the AI-enabled Esper virtual health assistantâ„¢ and clinical insights and analytics that help power more informed decision-making, earlier interventions, and better care and outcomes.
"We are honored to be acknowledged as one of the leading Remote Patient Monitoring companies by AVIA," said Janet Dillione, CEO of Connect America. "With the rising need for remote monitoring, the 100Plus RPM solution was introduced with an explicit goal of reducing patient, clinician, and health care system barriers to RPM use and to improve health and cost outcomes. Today, we are proud that 69% of providers using our 100Plus RPM solution believe it has reduced or greatly reduced the incidence of hospitalizations and other forms of high acuity care, and it consistently drives a 92% customer satisfaction rate while improving clinical efficiencies. "
The Top Remote Patient Monitoring Companies Report represents the aggregation and analysis of client ratings and reviews as well as health system implementation data across the country and highlights broader industry trends to contextualize the impact the companies and products are currently having in the space. Given the complexity and evolving nature of remote patient monitoring, the 2023 refresh of this report helps define the remote patient monitoring landscape and how these solutions best support patient care.
"With the rise of Remote Patient Monitoring solutions, a transformative shift in patient care is imminent. Our report illuminates the trailblazers making significant strides in this field," said Dhiraj Patkar, SVP of Digital Health Solutions at AVIA. "Our objective with the Top Remote Patient Monitoring Companies Report is to arm healthcare organizations with comprehensive insights and tools crucial for the successful deployment and expansion of these advanced digital solutions. Leveraging digital technologies, we can extend care access, optimize patient experiences and outcomes, and tackle the escalating challenges that healthcare providers encounter in today's multifaceted landscape."
###
AVIA Marketplace is where innovative health systems and hospitals go to find the right digital health solutions. It's built to efficiently search vendors and guide informed decisions, with tools like product comparisons, match scores, report generators, peer reviews, and market insights.
Access the full report findings from AVIA Marketplace's Top Remote Patient Monitoring Companies list here.
About Connect America
Connect America, and its family of brands, is the leading provider of connective health solutions dedicated to empowering aging adults and vulnerable populations to live safely and independently at home for as long as possible. The company's AI-assisted digital health and safety platform includes Remote Patient Monitoring (RPM) solutions, Personal Emergency Response Services (PERS), Medication Management, Analytics, and SDoH support that enables continuous in-home and mobile monitoring of aging and at-risk populations for more timely interventions and smart escalations of care. With improved outcomes, reduced hospitalizations and lower care costs, patients and their care circles have peace of mind knowing Connect America is how health and home connect. To learn more, visit https://www.connectamerica.com.
Sean Chase
AVIA Press Contact
[email protected]
(603) 307-9428
Jane MacPherson
Communications Manager
[email protected]
16473027164
Original Source: Connect America Named to AVIA Marketplace's Top Remote Patient Monitoring Companies
Lonseth Interventional Pain Centers Launches Spinal Cord Stimulator Trials for Diabetic Peripheral Neuropathy
METAIRIE, La., June 19, 2023 (Newswire.com) - Lonseth Interventional Pain Centers, a renowned provider of pain management solutions, proudly announces the offering of Spinal Cord Stimulator (SCS) Trials for individuals affected by chronic pain conditions, including Diabetic Peripheral Neuropathy. These Medicare-covered trials are a game-changing recourse for patients who haven't found sufficient relief from conventional treatments.
SCS Trials involve the temporary implantation of a device that emits low-level electrical signals to the spinal cord or specific nerves, effectively blocking the transmission of pain signals to the brain. This outpatient procedure, conducted under the guidance of trained professionals, allows patients to experience the potential benefits of SCS without committing to a permanent implantation.
The trial period lasts about a week. After which, patients and their physicians evaluate the effectiveness of the treatment. Successful trials, typically marked by a significant reduction in pain, may lead to the patient becoming a candidate for permanent SCS implantation.
SCS is a progressive therapy involving a device that sends mild electrical currents to the spinal cord, mitigating chronic pain. This technique is particularly useful after conventional non-surgical treatments have proven insufficient. It is programmable to target specific pain areas, making it an effective option for various chronic pain conditions.
During an SCS trial, patients can expect careful preparation, expert execution of the procedure, and a personalized adjustment process to ensure optimal pain control. After the procedure, they take home the trial stimulator for several days to assess its effectiveness in their daily lives.
Candidates for these Medicare-covered SCS trials typically include those with chronic pain impacting daily activities who have not found relief from other treatments, who do not suffer from untreated drug addiction, and who have successfully managed any underlying psychiatric conditions. Moreover, patients should be healthy enough to undergo the procedure safely.
Lonseth Interventional Pain Centers is pleased to confirm that these revolutionary SCS trials are Medicare-covered. Its dedicated team stands ready to support patients through each phase, providing them with a comforting, informed experience.
People don't have to let chronic pain rule their life. They can begin a journey toward less pain by reaching out to Lonseth Interventional Pain Centers to schedule a consultation and find out if they qualify for SCS trials. This groundbreaking therapy could be the key to a new, less painful chapter of their life.
Contact Information:Eric Lonseth
Doctor
[email protected]
(504) 732-1094
Original Source: Lonseth Interventional Pain Centers Launches Spinal Cord Stimulator Trials for Diabetic Peripheral Neuropathy
